Active, not recruitingPhase 2NCT05983588
PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)
Studying Corticobasal syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Technical University of Munich
- Intervention
- RAVICTI 1.1 g/ml(drug)
- Enrollment
- 32 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (2)
- Klinikum der Universität München (KUM), Campus Großhadern, Klinik und Poliklinik für Neurologie & German Center for Neurodegenerative Diseases (DZNE), Department of Neurology, Munich, Bavaria, Germany
- Klinikum rechts der Isar Technische Universität München Klinik und Poliklinik für Neurologie & German Center for Neurodegenerative Diseases (DZNE), Department of Neurology, Munich, Bavaria, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05983588 on ClinicalTrials.govOther trials for Corticobasal syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06613204STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care PartnersOregon Health and Science University
- RECRUITINGNCT06647641The CurePSP Genetics ProgramMassachusetts General Hospital
- RECRUITINGNANCT05653778Scrambler Therapy for Corticobasal Syndrome-Associated PainJohns Hopkins University
- ACTIVE NOT RECRUITINGNANCT05073471Music and Brain Stimulation for Upper Extremity Performance in Patients With Corticobasal SyndromeJohns Hopkins University